Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products

Drugmaker Novartis filed suit to block Maryland's recently signed 340B contract pharmacy statute.
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Contract Pharmacy Protection Bill Introduced in NY Senate; Lawmakers Target Other 340B Matters

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
A key New York senator has introduced legislation that would bar pharmaceutical manufacturers and pharmacy benefit managers (PBMs) from discriminating [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Adds Biologic to Contract Pharmacy Restrictions

Pharmaceutical giant Merck has added a new medication for pulmonary arterial hypertension to its 340B contract pharmacy restrictions.
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Governor Signs Bill Targeting 340B In-Kind Funding

Tennessee Gov. Bill Lee (R) signed into law a bill requiring STD clinics to enter into contracts with the state to receive 340B in-kind funding.
Tennessee sexually transmitted disease (STD) clinics will need to have contracts in place with the state to receive 340B in-kind [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

MedPAC Analysis Estimates Medicare Part B Payments to 340B Hospitals are Significantly Higher than Ceiling Prices

A MedPAC analysis found that Medicare paid 340B hospitals significantly more than the ceiling price for dozens of medications in 2022.
Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Survey Finds FQHC Prescribers May Need More Education on 340B Program

A survey published in the American Journal of Health-System Pharmacy found some FQHC prescribers need more information on the 340B program.
Prescribers who work in federally qualified health centers (FQHCs) believe the 340B program helps their organizations and patients—even if they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Names Britton As New Leader of Office Overseeing 340B Program

The Health Resources and Services Administration (HRSA) on Monday announced Chantelle Britton as its next Office of Pharmacy Affairs (OPA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Oregon Enacts 340B Anti-Discrimination Protections in PBM Regulations

Oregon Gov. Tina Kotek (D) recently signed a bill with prohibitions on certain 340B-specific PBM and payer policies.
Pharmacy benefit managers (PBMs) and insurers operating in Oregon are barred from restricting 340B drug dispensing or limiting the number [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Bill Targeting 340B In-Kind Funding Heads to Governor’s Desk

The Tennessee legislature cleared a bill, by state Rep. Esther Helton-Haynes (R), that tightens requirements for 340B in-kind funding for STD clinics.
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live